AG
FBIO icon

Advisor Group’s Fortress Biotech FBIO Stock Holding History

Advisor Group’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Sell
1
-953
-100% -$24.5K ﹤0.01% 5344
2019
Q3 		$20K Buy
954
+953
+95,300% +$22.4K ﹤0.01% 3957
2019
Q2 		$0 Hold
1
– – ﹤0.01% 5263
2019
Q1 		$0 Hold
1
– – ﹤0.01% 5240
2018
Q4 		$0 Hold
1
– – ﹤0.01% 5131
2018
Q3 		$0 Hold
1
– – ﹤0.01% 5132
2018
Q2 		$0 Buy
+1
New +$56 ﹤0.01% 4961

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Advisor Group's FBIO Position: Q4 2019 in Review

Advisor Group reduced its Fortress Biotech (FBIO) stake by 100% in Q4 2019, selling an estimated $24.5K and leaving 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5344.

Advisor Group first reported a position in FBIO in Q2 2018 and has held it in 7 quarters since. The position peaked at $20K in Q3 2019. 54 funds tracked by Wall St. Rank hold FBIO as of Q4 2019.

  • Advisor Group held 1 share of Fortress Biotech worth $0 as of Q4 2019.
  • Advisor Group sold 953 Fortress Biotech shares in Q4 2019, an estimated $24.5K.
  • Fortress Biotech made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5344 holding.
  • Advisor Group first reported a position in Fortress Biotech in Q2 2018 and has held it in 7 quarters since.
  • Advisor Group's Fortress Biotech position peaked at $20K in Q3 2019.
  • 54 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.